Nine Chapters Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Nine Chapters Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$395K	Buy	+6,200	New	+$362K	0.87%	40
2014 Q2	–	Sell	-21,900	Closed	-$1.14M	–	945
2014 Q1	$1.14M	Buy	+21,900	New	+$1.17M	0.13%	220

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nine Chapters Capital Management's BMY Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2017: 6,200 shares worth $395K. The stake represents 0.87% of the portfolio and ranks #40 among its holdings. This is a return to the name: Nine Chapters Capital Management previously reported a position in BMY as recently as Q1 2014.

Nine Chapters Capital Management first reported a position in BMY in Q1 2014 and has held it in 2 quarters since. The position peaked at $1.14M in Q1 2014. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Nine Chapters Capital Management held 6,200 shares of Bristol-Myers Squibb worth $395K as of Q3 2017.
Bristol-Myers Squibb was a new Nine Chapters Capital Management position in Q3 2017.
Bristol-Myers Squibb made up 0.87% of Nine Chapters Capital Management's portfolio in Q3 2017, its #40 holding.
Nine Chapters Capital Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 2 quarters since.
Nine Chapters Capital Management's Bristol-Myers Squibb position peaked at $1.14M in Q1 2014.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.